Affymax, Inc. (AFFY)
OTCMKTS · Delayed Price · Currency is USD
0.0009
0.00 (0.00%)
Nov 3, 2025, 4:00 PM EST
Affymax Revenue
Affymax had revenue of $42.00K in the quarter ending June 30, 2014, a decrease of -92.00%. This brings the company's revenue in the last twelve months to $42.00K, down -99.86% year-over-year. In the year 2013, Affymax had annual revenue of $1.37M, down -98.55%.
Revenue (ttm)
42.00K
Revenue Growth
-99.86%
P/S Ratio
1.60
Revenue / Employee
21.00K
Employees
2
Market Cap
67.04K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2013 | 1.37M | -93.00M | -98.55% |
| Dec 31, 2012 | 94.37M | 46.65M | 97.76% |
| Dec 31, 2011 | 47.72M | -64.80M | -57.59% |
| Dec 31, 2010 | 112.52M | -2.38M | -2.07% |
| Dec 31, 2009 | 114.90M | 32.05M | 38.68% |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2005 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2004 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| China New Energy Group Co. | 12.51M |
| Northwest Biotherapeutics | 1.09M |